Farahnaz Behzad
Overview
Explore the profile of Farahnaz Behzad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moghadasi S, Elveny M, Rahman H, Suksatan W, Turki Jalil A, Abdelbasset W, et al.
J Transl Med
. 2025 Mar;
23(1):273.
PMID: 40038699
No abstract available.
2.
Behzad F, Samadi A, Rahimpour E, Adabi M, Jouyban A
Bioanalysis
. 2023 Feb;
14(23):1509-1524.
PMID: 36799230
Aptasensors are amazing among many currently formed procedures due to their excellent particularity, selectivity and responsiveness. These biosensors get more popular in combination with gold nanoparticles (AuNPs) to detect chemical...
3.
Moghadasi S, Elveny M, Rahman H, Suksatan W, Turki Jalil A, Abdelbasset W, et al.
J Transl Med
. 2021 Jul;
19(1):302.
PMID: 34253242
Recently, mesenchymal stem/stromal cells (MSCs) due to their pro-angiogenic, anti-apoptotic, and immunoregulatory competencies along with fewer ethical issues are presented as a rational strategy for regenerative medicine. Current reports have...
4.
Behzad F, Sefidgar E, Samadi A, Lin W, Pouladi I, Pi J
Curr Med Chem
. 2021 Jun;
29(1):86-98.
PMID: 34126883
Tuberculosis (TB), induced by Mycobacterium tuberculosis (MTB), is a fatal infectious disease that kills millions of lives worldwide. The emergence of drug-resistant and multidrug-resistant cases is regarded as one of...
5.
Nasirmoghadas P, Mousakhani A, Behzad F, Beheshtkhoo N, Hassanzadeh A, Nikoo M, et al.
Biotechnol Prog
. 2020 Aug;
37(2):e3070.
PMID: 32829506
Cancer has been one of the most significant causes of mortality, worldwide. Cancer immunotherapy has recently emerged as a competent, cancer-fighting clinical strategy. Nevertheless, due to the difficulty of such...